Folate-mediated delivery of macromolecular anticancer therapeutic agents
Tóm tắt
Từ khóa
Tài liệu tham khảo
Maeda, 2001, The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting, Adv. Enzyme Regul., 41, 189, 10.1016/S0065-2571(00)00013-3
Netti, 1995, Time-dependent behavior of interstitial fluid pressure in solid tumors: implications for drug delivery, Cancer Res., 55, 5451
Nakashima-Matsushita, 1999, Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis, Arthritis Rheum., 42, 1609, 10.1002/1529-0131(199908)42:8<1609::AID-ANR7>3.0.CO;2-L
M.J. Turk, G.J. Breur, W.R. Widmer, C.M. Paulos, L. Xu, L.A. Grote, P.S. Low, Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis, Arthritis Rheum., in press.
Antony, 1992, The biological chemistry of folate receptors, Blood, 79, 2807, 10.1182/blood.V79.11.2807.2807
Garin-Chesa, 1993, Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein, Am. J. Pathol., 142, 557
Toffoli, 1997, Overexpression of folate binding protein in ovarian cancers, Int. J. Cancer, 74, 193, 10.1002/(SICI)1097-0215(19970422)74:2<193::AID-IJC10>3.0.CO;2-F
Gruner, 1998, The folate receptor as a potential therapeutic anticancer target, Invest. New Drugs, 16, 205, 10.1023/A:1006147932159
Reddy, 1998, Folate-mediated targeting of therapeutic and imaging agents to cancers, Crit. Rev. Ther. Drug Carrier Syst., 15, 587, 10.1615/CritRevTherDrugCarrierSyst.v15.i6.20
Sudimack, 2000, Targeted drug delivery via the folate receptor, Adv. Drug Deliv. Rev., 41, 147, 10.1016/S0169-409X(99)00062-9
Shen, 1994, Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity, Biochemistry, 33, 1209, 10.1021/bi00171a021
Wang, 1992, Differential stereospecificities and affinities of folate receptor isoforms for folate compounds and antifolates, Biochem. Pharmacol., 44, 1898, 10.1016/0006-2952(92)90089-2
Kamen, 1986, Properties of a folate binding protein (FBP) isolated from porcine kidney, Biochem. Pharmacol., 35, 2323, 10.1016/0006-2952(86)90458-2
da Costa, 1996, Purification and characterization of folate binding proteins from rat placenta, Biochim. Biophys. Acta, 1292, 23, 10.1016/0167-4838(95)00180-8
Shen, 1995, Folate receptor type gamma is primarily a secretory protein due to lack of an efficient signal for glycosylphosphatidylinositol modification: protein characterization and cell type specificity, Biochemistry, 34, 5660, 10.1021/bi00016a042
Spiegelstein, 2000, Identification of two putative novel folate receptor genes in humans and mouse, Gene, 258, 117, 10.1016/S0378-1119(00)00418-2
Ross, 1994, Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications, Cancer, 73, 2432, 10.1002/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S
Wu, 1999, Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix, Cancer Epidemiol. Biomarkers Prev., 8, 775
Weitman, 1994, The folate receptor in central nervous system malignancies of childhood, J. Neurooncol., 21, 107, 10.1007/BF01052894
Bueno, 2001, The alpha folate receptor is highly activated in malignant pleural mesothelioma, J. Thorac. Cardiovasc. Surg., 121, 225, 10.1067/mtc.2001.111176
Toffoli, 1998, Expression of folate binding protein as a prognostic factor for response to platinum-containing chemotherapy and survival in human ovarian cancer, Int. J. Cancer, 79, 121, 10.1002/(SICI)1097-0215(19980417)79:2<121::AID-IJC4>3.0.CO;2-V
Ross, 1999, Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia, Cancer, 85, 348, 10.1002/(SICI)1097-0142(19990115)85:2<348::AID-CNCR12>3.0.CO;2-4
Reddy, 1999, Expression and functional characterization of the beta-isoform of the folate receptor on CD34(+) cells, Blood, 93, 3940, 10.1182/blood.V93.11.3940
Weitman, 1992, Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis, Cancer Res., 52, 6708
Patrick, 1997, Folate receptors as potential therapeutic targets in choroid plexus tumors of SV40 transgenic mice, J. Neurooncol., 32, 111, 10.1023/A:1005713115147
Birn, 1997, Internalization and apical-to-basolateral transport of folate in rat kidney proximal tubule, Am. J. Physiol., 272, F70
Leamon, 1991, Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis, Proc. Natl. Acad. Sci. USA, 88, 5572, 10.1073/pnas.88.13.5572
Turek, 1993, Endocytosis of folate–protein conjugates: ultrastructural localization in KB cells, J. Cell. Sci., 106, 423, 10.1242/jcs.106.1.423
Rothberg, 1990, Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltetrahydrofolate, J. Cell Biol., 111, 2931, 10.1083/jcb.111.6.2931
Mayor, 1994, Sequestration of GPI-anchored proteins in caveolae triggered by cross-linking, Science, 264, 1948, 10.1126/science.7516582
Rothberg, 1990, The glycophospholipid-linked folate receptor internalizes folate without entering the clathrin-coated pit endocytic pathway, J. Cell Biol., 110, 637, 10.1083/jcb.110.3.637
Anderson, 1992, Potocytosis: sequestration and transport of small molecules by caveolae, Science, 255, 410, 10.1126/science.1310359
Wu, 1997, Clustering of GPI-anchored folate receptor independent of both cross-linking and association with caveolin, J. Membr. Biol., 159, 137, 10.1007/s002329900277
Varma, 1998, GPI-anchored proteins are organized in submicron domains at the cell surface, Nature, 394, 798, 10.1038/29563
Kamen, 1986, Receptor-mediated folate accumulation is regulated by the cellular folate content, Proc. Natl. Acad. Sci. USA, 83, 5983, 10.1073/pnas.83.16.5983
Lee, 1996, Measurement of endosome pH following folate receptor-mediated endocytosis, Biochim. Biophys. Acta, 1312, 237, 10.1016/0167-4889(96)00041-9
Mathias, 1996, Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67–deferoxamine–folate, J. Nucl. Med., 37, 1003
Mathias, 1998, Indium-111–DTPA–folate as a potential folate-receptor-targeted radiopharmaceutical, J. Nucl. Med., 39, 1579
Guo, 1999, 99mTc–HYNIC–folate: a novel receptor-based targeted radiopharmaceutical for tumor imaging, J. Nucl. Med., 40, 1563
Leamon, 2001, Folate-mediated targeting: from diagnostics to drug and gene delivery, Drug Discov. Today, 6, 44, 10.1016/S1359-6446(00)01594-4
Leamon, 1992, Cytotoxicity of momordin–folate conjugates in cultured human cells, J. Biol. Chem., 267, 24966, 10.1016/S0021-9258(19)73992-1
Leamon, 1993, Cytotoxicity of folate–Pseudomonas exotoxin conjugates toward tumor cells. Contribution of translocation domain, J. Biol. Chem., 268, 24847, 10.1016/S0021-9258(19)74542-6
Atkinson, 2001, Conjugation of folate via gelonin carbohydrate residues retains ribosomal-inactivating properties of the toxin and permits targeting to folate receptor positive cells, J. Biol. Chem., 276, 27930, 10.1074/jbc.M102825200
Lee, 1995, Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro, Biochim. Biophys. Acta, 1233, 134, 10.1016/0005-2736(94)00235-H
S.M. Stephenson, P.S. Low, R.J. Lee, Folate receptor mediated targeting of liposomal drugs to cancer cells, Methods Enzymol., in press.
Goren, 2000, Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump, Clin. Cancer Res., 6, 1949
Wang, 1995, Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol, Proc. Natl. Acad. Sci. USA, 92, 3318, 10.1073/pnas.92.8.3318
Ginobbi, 1997, Folic acid–polylysine carrier improves efficacy of c-myc antisense oligodeoxynucleotides on human melanoma (M14) cells, Anticancer Res., 17, 29
Li, 1998, Folate-mediated targeting of antisense oligodeoxynucleotides to ovarian cancer cells, Pharm. Res., 15, 1540, 10.1023/A:1011946915209
Lee, 1996, Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer, J. Biol. Chem., 271, 8481, 10.1074/jbc.271.14.8481
Douglas, 1996, Targeted gene delivery by tropism-modified adenoviral vectors, Nat. Biotechnol., 14, 1574, 10.1038/nbt1196-1574
Xu, 2001, Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy, J. Control. Release, 74, 115, 10.1016/S0168-3659(01)00324-8
Stella, 2000, Design of folic acid-conjugated nanoparticles for drug targeting, J. Pharm. Sci., 89, 1452, 10.1002/1520-6017(200011)89:11<1452::AID-JPS8>3.0.CO;2-P
Rihova, 1998, Receptor-mediated targeted drug or toxin delivery, Adv. Drug Deliv. Rev., 29, 273, 10.1016/S0169-409X(97)00084-7
Kataoka, 2001, Block copolymer micelles for drug delivery: design, characterization and biological significance, Adv. Drug Deliv. Rev., 47, 113, 10.1016/S0169-409X(00)00124-1
Lu, 1999, Folate-targeted enzyme prodrug cancer therapy utilizing penicillin-V amidase and a doxorubicin prodrug, J. Drug Target., 7, 43, 10.3109/10611869909085491
Kranz, 1995, Conjugates of folate and anti-T-cell-receptor antibodies specifically target folate-receptor-positive tumor cells for lysis, Proc. Natl. Acad. Sci. USA, 92, 9057, 10.1073/pnas.92.20.9057
Lu, 2002, Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors, Cancer Immunol. Immunother., 51, 153, 10.1007/s00262-002-0266-6
Leamon, 1994, Selective targeting of malignant cells with cytotoxin–folate conjugates, J. Drug Target., 2, 101, 10.3109/10611869409015898
Leamon, 1999, Folate-mediated drug delivery: effect of alternative conjugation chemistry, J. Drug Target., 7, 157, 10.3109/10611869909085499
Shinoda, 1998, In vivo fate of folate-BSA in non-tumor- and tumor-bearing mice, J. Pharm. Sci., 87, 1521, 10.1021/js980215v
Ward, 2000, Folic acid targeting of protein conjugates into ascites tumour cells from ovarian cancer patients, J. Drug Target., 8, 119, 10.3109/10611860008996857
Drummond, 2000, Liposome targeting to tumors using vitamin and growth factor receptors, Vitam. Horm., 60, 285, 10.1016/S0083-6729(00)60022-5
Vyas, 2001, Ligand–receptor-mediated drug delivery: an emerging paradigm in cellular drug targeting, Crit. Rev. Ther. Drug Carrier Syst., 18, 1, 10.1615/CritRevTherDrugCarrierSyst.v18.i1.10
Lee, 1994, Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis, J. Biol. Chem., 269, 3198, 10.1016/S0021-9258(17)41848-5
Lee, 1998, The effects of pH and intraliposomal buffer strength on the rate of liposome content release and intracellular drug delivery, Biosci. Rep., 18, 69, 10.1023/A:1020132226113
Gabizon, 1999, Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies, Bioconjug. Chem., 10, 289, 10.1021/bc9801124
Woodle, 1992, Sterically stabilized liposomes, Biochim. Biophys. Acta, 1113, 171, 10.1016/0304-4157(92)90038-C
Papahadjopoulos, 1990, Liposomes designed to avoid the reticuloendothelial system, Prog. Clin. Biol. Res., 343, 85
Vogel, 1996, Peptide-mediated release of folate-targeted liposome contents from endosomal compartments, J. Am. Chem. Soc., 118, 1581, 10.1021/ja952725m
Rui, 1998, Diplasmenylcholine–folate liposomes: an efficient vehicle for intracellular drug delivery, J. Am. Chem. Soc., 120, 11213, 10.1021/ja9742949
Qualls, 2001, Chloroaluminum phthalocyanine tetrasulfonate delivered via acid-labile diplasmenylcholine–folate liposomes: intracellular localization and synergistic phototoxicity, Int. J. Cancer, 93, 384, 10.1002/ijc.1339
Guo, 2000, Receptor-specific delivery of liposomes via folate–PEG-chol, J. Liposome Res., 10, 179, 10.3109/08982100009029385
Mellman, 1996, Endocytosis and molecular sorting, Annu. Rev. Cell Dev. Biol., 12, 575, 10.1146/annurev.cellbio.12.1.575
Pouton, 1998, Polycation–DNA complexes for gene delivery: a comparison of the biopharmaceutical properties of cationic polypeptides and cationic lipids, J. Control. Release, 53, 289, 10.1016/S0168-3659(98)00015-7
Reddy, 1999, Optimization of folate-conjugated liposomal vectors for folate receptor-mediated gene therapy, J. Pharm. Sci., 88, 1112, 10.1021/js990169e
Turk, 2002, Characterization of a novel pH-sensitive peptide that enhances drug release from folate targeted liposomes at endosomal pHs, Biochim. Biophys. Acta, 1559, 56, 10.1016/S0005-2736(01)00441-2
Reddy, 2000, Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation, J. Control. Release, 64, 27, 10.1016/S0168-3659(99)00135-2
Kirpotin, 1997, Targeting of liposomes to solid tumors: the case of sterically stabilized anti-HER2 immunoliposomes, J. Liposome Res., 7, 391, 10.3109/08982109709035509
Pizzato, 2001, Evidence for nonspecific adsorption of targeted retrovirus vector particles to cells, Gene Ther., 8, 1088, 10.1038/sj.gt.3301494
Reddy, 2001, Retargeting of viral vectors to the folate receptor endocytic pathway, J. Control. Release, 74, 77, 10.1016/S0168-3659(01)00316-9
Mislick, 1995, Transfection of folate–polylysine DNA complexes: evidence for lysosomal delivery, Bioconjug. Chem., 6, 512, 10.1021/bc00035a002
Leamon, 1999, Folate copolymer-mediated transfection of cultured cells, Bioconjug. Chem., 10, 947, 10.1021/bc990066n
Guo, 1999, Receptor-targeted gene delivery via folate-conjugated polyethylenimine, AAPS PharmSci., 1, E19, 10.1208/ps010419
Leong, 1998, DNA-polycation nanospheres as non-viral gene delivery vehicles, J. Control. Release, 53, 183, 10.1016/S0168-3659(97)00252-6
Yokoyama, 1998, Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor, J. Control. Release, 50, 79, 10.1016/S0168-3659(97)00115-6
Nishiyama, 2001, Cisplatin-loaded polymer–metal complex micelle with time-modulated decaying property as a novel drug delivery system, Pharm. Res., 18, 1035, 10.1023/A:1010908916184
Springer, 1997, Antibody-directed enzyme prodrug therapy (ADEPT): a review, Adv. Drug Deliv. Rev., 26, 151, 10.1016/S0169-409X(97)00032-X
Patrick, 1998, Intracerebral bispecific ligand–antibody conjugate increases survival of animals bearing endogenously arising brain tumors, Int. J. Cancer, 78, 470, 10.1002/(SICI)1097-0215(19981109)78:4<470::AID-IJC13>3.0.CO;2-A
Roy, 1998, Targeting T cells against brain tumors with a bispecific ligand–antibody conjugate, Int. J. Cancer, 76, 761, 10.1002/(SICI)1097-0215(19980529)76:5<761::AID-IJC23>3.0.CO;2-5